Clinical Trial Update: Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM) [Phase 3]

View source ↗

Summary

Phase 3 DREAM trial evaluating maintenance bevacizumab with or without erlotinib after optimized chemotherapy in unresectable metastatic colorectal cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Tarceva (erlotinib)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED